Tag: Pharmaceuticals
Business & Industry
Drug Manufacturing Deals Shift to Europe Despite Tariffs
Biopharma companies are continuing to redirect production strategies toward Europe, even as U.S. policymakers attempt to strengthen domestic output through tariffs and onshoring measures....
Business & Industry
Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition
Neurocrine Biosciences is close to securing a more than $2.5bn acquisition of Soleno Therapeutics, the developer of a treatment for a rare genetic form...
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Articles
The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement
Why Field Execution Must Evolve
Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and...
Business & Industry
Trump Announces 100% US Pharma Tariffs for Patented Drugs
The US pharma tariffs policy has been formalised through an executive order signed by Donald Trump, introducing tariffs of up to 100% on imported...
Business & Industry
UK-US Pharma Trade Deal Drives Tariff Cuts, Pricing Shift
Britain has finalised a UK-US pharma trade deal, securing tariff-free access for UK-made medicines to the United States while committing to higher domestic spending...
Business & Industry
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly & Co. is set to acquire Centessa Pharmaceuticals Plc in a transaction worth up to $7.8 billion, underscoring its push to broaden...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read